STOCK TITAN
  1. Home
  2. Sec-filings
  3. MGTX
  4. [Form 4] MeiraGTx Holdings plc Insider Trading Activity

[Form 4] MeiraGTx Holdings plc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MGTX logo
Meiragtx Holdings Plc

NASDAQ:MGTX

MGTX Rankings

#3117 Ranked by Market Cap
N/A Ranked by Dividends

MGTX Latest News

Aug 14, 2025
MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
May 13, 2025
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
May 13, 2025
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
May 9, 2025
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
Mar 13, 2025
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

MGTX Latest SEC Filings

Aug 14, 2025
[10-Q] MeiraGTx Holdings plc Quarterly Earnings Report
Aug 14, 2025
[8-K] MeiraGTx Holdings plc Reports Material Event
Jul 22, 2025
[144] MeiraGTx Holdings plc SEC Filing
Jul 8, 2025
[Form 4] MeiraGTx Holdings plc Insider Trading Activity
Jul 8, 2025
[144] MeiraGTx Holdings plc SEC Filing

MGTX Stock Data

642.78M
48.23M
24.15%
64.97%
4.35%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK